Showing results (191-200 of 271) with videos related to
Sort By:
Pageof 28
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 29, 2011
Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4(Dpc4) immunostaining with pattern of disease progressionChristopher H Crane, Gauri R Varadhachary, John S Yordy, et al.Cancer|October 27, 2011
Histologic grading of the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma: a predictor for patient outcomeDeyali Chatterjee, Matthew H Katz, Asif Rashid, et al.Journal of the American College of Surgeons|May 13, 2008
Borderline resectable pancreatic cancer: the importance of this emerging stage of diseaseMatthew H G Katz, Peter W T Pisters, Douglas B Evans, et al.Acta Oncologica (Stockholm, Sweden)|January 23, 2015
Paraneoplastic thrombocytosis independently predicts poor prognosis in patients with locally advanced pancreatic cancerAwalpreet S Chadha, Esengul Kocak-Uzel, Prajnan Das, et al.The American Journal of Surgical Pathology|July 23, 2015
Superior Mesenteric Artery Margin of Posttherapy Pancreaticoduodenectomy and Prognosis in Patients With Pancreatic Ductal AdenocarcinomaLi Liu, Matthew H Katz, Sun M Lee, et al.Biomaterials|January 15, 2018
Simultaneous inhibition of hedgehog signaling and tumor proliferation remodels stroma and enhances pancreatic cancer therapyJun Zhao, Huamin Wang, Cheng-Hui Hsiao, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2015
IL1 Receptor Antagonist Inhibits Pancreatic Cancer Growth by Abrogating NF-κB ActivationZhuonan Zhuang, Huai-Qiang Ju, Mitzi Aguilar, et al.Abdominal Radiology (New York)|November 22, 2019
White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology's disease-focused panel for pancreatic ductal adenocarcinoma: Part I, AJCC staging system, NCCN guidelines, and borderline resectable diseaseNaveen M Kulkarni, Erik V Soloff, Parag P Tolat, et al.Pancreas|September 14, 2017
Prognostic Significance of Tumor-Infiltrating Lymphocytes in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant ChemotherapyReza Nejati, Jennifer B Goldstein, Daniel M Halperin, et al.JCO Precision Oncology|July 12, 2021
Identification of Targetable Gene Fusions and Structural Rearrangements to Foster Precision Medicine in <i>KRAS</i> Wild-Type Pancreatic CancerMichael J Fusco, Daryoush Saeed-Vafa, Estrella M Carballido, et al.Pageof 28